Navigation Links
ThalesNano Inc. and the Christian Doppler Laboratory for Microwave Chemistry in Graz, Austria Collaborate on Flow Chemistry Technologies
Date:11/19/2007

application development and contributed significantly to the general acceptance of microwave technologies so far."

For more information please go to: http://www.thalesnano.com

About ThalesNano Inc.

ThalesNano is a world-leading provider of flow chemistry instruments for laboratories with well over 50% share on the explosively developing market of laboratory flow reactors. Its H-CubeTM , continuous-flow hydrogenation reactors with no outside hydrogen gas source (also available for scale up), has been used in hundreds of labs in four continents. After being awarded as one of the 100 most technologically significant and innovative new products of 2005 by the R&D Magazine, ThalesNano this year successfully generalized the concept of H-Cube by creating and bringing to the market the X-Cube, a high-pressure, high-temperature general purpose flow reactor for liquid or liquid/gas phase reactions. Apart from instrument development, ThalesNano provides synthetic and scale-up solutions to the industry, together with training and technical support.

Flow chemistry, an emerging technology allows the highly effective and rapid synthesis of organic compounds, in particular under hitherto unrealizable hazardous reaction conditions. Additional benefits are seen in the area of green chemistry and lab automation. This technology furthermore promotes the rapid scale-up from mg to kg quantities with quick turnover, high quality stabilization, and reduced footprint leading to minimized CAPEX and OPEX

About Christian Doppler Research Association

The Austrian Christian Doppler Research Association (CDG) is a non-profit association that aims at promoting application oriented basic research in the areas of natural sciences, technology and economy. It enables talented scientists in renowned research centers to achieve high-quality research and knowledge transfer in line with the demands and to the advanta
'/>"/>

SOURCE ThalesNano Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Laboratory at UI plays major role in diagnosing cancer
2. Instrumentation Laboratory Named Top of Class by Respiratory Care Managers
3. Epilepsy-induced brain cell damage prevented in the laboratory
4. Story tips from the Department of Energys Oak Ridge National Laboratory, Nov. 2007
5. Genes, brain chemistry may dictate nicotine cravings, says CU-Boulder study
6. Histochemistry is the golden standard in the diagnosis of carcinosarcomas
7. Recovery Resources Collaborates with Two Nonprofit Agencies for Children of Alcoholics Outreach Program
8. MU researchers to collaborate on $20 million project
9. AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks with ADHD Medications
10. The American Pain Foundation (APF) and The HealthCentral Network Collaborate to Develop Enhanced Internet Resources for People with Pain
11. EHRVA Members Collaborate to Demonstrate Interoperability Success at NCHICA
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:eDiets.com(R) Announces Q3 2008 Results 2Health News:eDiets.com(R) Announces Q3 2008 Results 3Health News:eDiets.com(R) Announces Q3 2008 Results 4Health News:eDiets.com(R) Announces Q3 2008 Results 5Health News:eDiets.com(R) Announces Q3 2008 Results 6Health News:eDiets.com(R) Announces Q3 2008 Results 7Health News:Pelvic Inflammation Puts Girls at Risk for Repeat STIs 2Health News:Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer 2Health News:Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer 3Health News:Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer 4Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 2Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 3Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 4Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 5Health News:Leading Scientists From Around the World Headed to Kansas for Symposium on Combating Deadly Infectious Diseases 2Health News: FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause 2Health News: FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause 3Health News: FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause 4
Breaking Medicine Technology:RetireSafe Announces Intention to Key Vote Senator Dorgan's Drug Importation Amendment (SA 2793) 2Dynatronics Receives 180-Day NASDAQ Extension 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3Abbott Declares 343rd Consecutive Quarterly Dividend 14129 1Medical Device Manufacturer MRPC Awarded ISO 13485 Certification 57543 1Medical Device Manufacturer MRPC Awarded ISO 13485 Certification 57543 2Global Med Technologies Inc s CEO to Make Major New Product Announcement the Morning of the LDV Investor Conference and Will Demo the Product on Wedn 57541 1Global Med Technologies Inc s CEO to Make Major New Product Announcement the Morning of the LDV Investor Conference and Will Demo the Product on Wedn 57541 2Global Med Technologies Inc s CEO to Make Major New Product Announcement the Morning of the LDV Investor Conference and Will Demo the Product on Wedn 57541 3